Ischemic Stroke News and Research

RSS

Pioneering treatment for stroke due to intracerebral hemorrhage

For decades, University of Cincinnati researchers have been pioneers in the field of stroke research.

16 Feb 2022

Mechanical clot removal may improve recovery after severe stroke in children

Serious disability was 6 times more likely to be the result three months after stroke among children whose clot-caused stroke in a large vessel (a type of ischemic stroke) was not treated with a procedure to extract the clot, according to preliminary late-breaking science presented today at the American Stroke Association's International Stroke Conference 2022.

12 Feb 2022

Stroke patients have higher chance of better outcomes when treated at Comprehensive Stroke Centers

When comparing outcomes for acute ischemic stroke patients treated at various levels of stroke centers, patients who received care at Comprehensive Stroke Centers (CSC) or Thrombectomy-capable Stroke Centers (TSC) were more likely to receive rapid treatment with clot-busting medication and/or mechanical clot removal and be discharged home or to rehabilitation centers than patients treated at Primary Stroke Centers, according to preliminary research to be presented today at the American Stroke Association's International Stroke Conference 2022.

12 Feb 2022

Mechanical blood clot removal helps nearly half of stroke survivors to achieve good outcomes

Mechanical removal of blood clots reduced post-stroke disability in nearly half of "all-comer" real-world stroke patients in an international study, according to preliminary late-breaking science presented today at the American Stroke Association's International Stroke Conference 2022.

11 Feb 2022

Newer clot-busting drug may lengthen the window for additional stroke treatment to 24 hours

If patients with clot-caused strokes obtain medical care more than 4½ hours after their symptoms are noticed, it is too late to receive the standard clot-busting medication alteplase.

11 Feb 2022

Mechanical clot removal may be effective and lead to better outcomes for stroke patients

Stroke patients previously considered unlikely to survive without severe disability may regain far more function if the blood clots (which cause an ischemic stroke) are mechanically removed in addition to standard medical therapy, according to preliminary late-breaking research presented today at the American Stroke Association's International Stroke Conference 2022, a world premier meeting for researchers and clinicians dedicated to the science of stroke and brain health, held in person in New Orleans and virtually, Feb. 9-11, 2022.

9 Feb 2022

Statement outlines five elements to optimize care for in-hospital stroke patients

Although hospitalized patients are in a monitored environment, stroke evaluation and treatment are often delayed compared to patients arriving with a stroke at the emergency department, contributing to higher rates of morbidity and mortality for in-hospital stroke, according to an American Heart Association scientific statement published online today in the Association's journal Stroke.

9 Feb 2022

Older adults have greatest stroke risk in the first three days after COVID-19 diagnosis

The risk of stroke among older adults diagnosed with COVID-19 was highest within the first three days of diagnosis, according to preliminary research to be presented at the American Stroke Association's International Stroke Conference 2022, a world premier meeting for researchers and clinicians dedicated to the science of stroke and brain health to be held in person in New Orleans and virtually, Feb. 8-11, 2022.

3 Feb 2022

Review highlights sex differences in ischemic stroke occurrence among young adults

Women ages 35 years and younger were 44% more likely to have an ischemic stroke (caused by blocked blood vessels in the brain) than their male counterparts, according to a new review of more than a dozen international studies on sex differences in stroke occurrence, published today in a Go Red for Women 2022 spotlight issue of Stroke, a peer-reviewed journal of the American Stroke Association, a division of the American Heart Association.

24 Jan 2022

Fast-tracked human stroke drug may also be a safe and powerful defense against dementia

A human stroke drug, fast-tracked by the Food and Drug Administration and soon entering Phase 3 clinical trials, shows intriguing signs that it might also be a safe and powerful defense against Alzheimer's and other forms of dementia.

1 Dec 2021

Study: About 1 in 100 COVID-19 patients likely develop central nervous system complications

The largest multi-institutional international study to date on brain complications of COVID-19 has found that approximately one in 100 patients hospitalized with COVID-19 will likely develop complications of the central nervous system.

29 Nov 2021

Assessing optimal stroke treatment using CTA imaging

Professor Gilberto Gonzalez discusses using a common imaging technique to decide on the best course of treatment for large vessel occlusion stroke patients.

29 Nov 2021

Tea and coffee consumption associated with lower risk of stroke and dementia

Researchers investigate the impact of coffee and tea separately and in combination on the risk of stroke and dementia.

18 Nov 2021

Raising awareness of stroke and how to prevent it

In this interview, we speak to Dr. Patrick Brouwer, the head of worldwide medical affairs for CERENOVUS, about stroke and how to prevent it.

From CERENOVUS 17 Nov 2021

Study finds lower-quality thrombectomy outcomes for Hispanic ischemic stroke patients

A study involving UT Southwestern neurology researchers found lower-quality outcomes for Hispanic ischemic stroke patients who receive endovascular thrombectomies than for comparable white and Black patients.

17 Nov 2021

SARS-CoV-2 vaccination lowers risk of several outcomes after breakthrough infection

Researchers at the University of Oxford have conducted a study showing that vaccination against coronavirus disease 2019 (COVID-19) is associated with a lower risk of several sequelae among those who experience breakthrough infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

28 Oct 2021

Compared to influenza, COVID-19 is more likely to cause venous thrombosis

New research published in the medRxiv* preprint server suggests that COVID-19 illness incurs a greater 90-day risk of venous thrombosis than the flu. However, arterial thrombosis remains a higher risk among people with the influenza virus.

24 Oct 2021

First-in-human study of DBS for post-stroke rehabilitation shows encouraging results

Targeting the dentate nucleus with deep brain stimulation (DBS) was safe and feasible for promoting post-stroke rehabilitation in a first-in-human study at Cleveland Clinic.

21 Oct 2021

Study identifies the role of a key cell receptor in efferocytosis after ischemic stroke

It's clear that taking out the trash is an essential process in maintaining a clean and tidy home. But did you know that your body has a similar process for waste removal in which damaged cells are "thrown out"? A research team in Japan has recently shed new light on the dynamics of this process—termed efferocytosis—following ischemic stroke.

18 Oct 2021

Three new genetic variants linked to fibromuscular dysplasia

Three new genetic variants that regulate gene expression in the arteries are connected to fibromuscular dysplasia, an arterial disease that can cause dangerous consequences for the heart and vessels, according to a new study.